Generated: December 12, 2017
DrugPatentWatch Database Preview
Furosemide - Generic Drug Details
« Back to Dashboard
What are the generic drug sources for furosemide and what is the scope of furosemide freedom to operate?
is the generic ingredient in two branded drugs marketed by Abraxis Pharm, Accord Hlthcare, Amneal Pharms Co, Astrazeneca, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Intl Medication, Luitpold, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Sanofi Aventis Us, Dava Pharms Inc, Ipca Labs Ltd, Ivax Sub Teva Pharms, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Watson Labs Teva, and Us Pharm Holdings, and is included in sixty NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-one drug master file entries for furosemide. Sixty-four suppliers are listed for this compound.
Pharmacology for furosemide
Medical Subject Heading (MeSH) Categories for furosemide
|Prinston Inc||FUROSEMIDE||furosemide||TABLET;ORAL||076796-001||Mar 26, 2004||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Baxter Hlthcare Corp||FUROSEMIDE||furosemide||INJECTABLE;INJECTION||202747-001||Jan 27, 2014||AP||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs||FUROSEMIDE||furosemide||INJECTABLE;INJECTION||070604-001||Jan 2, 1987||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Leading Pharma Llc||FUROSEMIDE||furosemide||TABLET;ORAL||077293-002||Nov 9, 2005||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Watson Labs Teva||FUROSEMIDE||furosemide||TABLET;ORAL||070528-001||Jan 7, 1986||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Sandoz||FUROSEMIDE||furosemide||TABLET;ORAL||018569-001||Approved Prior to Jan 1, 1982||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Dava Pharms Inc||FUROSEMIDE||furosemide||TABLET;ORAL||018415-002||Jul 27, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Abraxis Pharm||FUROSEMIDE||furosemide||INJECTABLE;INJECTION||019036-001||Aug 13, 1984||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|West-ward Pharms Int||FUROSEMIDE||furosemide||TABLET;ORAL||070086-001||Jan 24, 1986||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Kalapharm||FUROSEMIDE||furosemide||TABLET;ORAL||018868-002||Jun 28, 1983||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: furosemide
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.